IS6588A - Natríum-vetnis skiptis hindri af gerð 1 (NHE-1) - Google Patents

Natríum-vetnis skiptis hindri af gerð 1 (NHE-1)

Info

Publication number
IS6588A
IS6588A IS6588A IS6588A IS6588A IS 6588 A IS6588 A IS 6588A IS 6588 A IS6588 A IS 6588A IS 6588 A IS6588 A IS 6588A IS 6588 A IS6588 A IS 6588A
Authority
IS
Iceland
Prior art keywords
nhe
inhibitor
sodium
alternate type
hydrogen
Prior art date
Application number
IS6588A
Other languages
English (en)
Inventor
George Chen Weichao
David Cox Eric
Guzman-Perez Angel
Original Assignee
Pfizer Products, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products, Inc. filed Critical Pfizer Products, Inc.
Publication of IS6588A publication Critical patent/IS6588A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS6588A 2000-04-28 2002-10-21 Natríum-vetnis skiptis hindri af gerð 1 (NHE-1) IS6588A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28
PCT/IB2001/000277 WO2001083470A1 (en) 2000-04-28 2001-02-28 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)

Publications (1)

Publication Number Publication Date
IS6588A true IS6588A (is) 2002-10-21

Family

ID=22741697

Family Applications (2)

Application Number Title Priority Date Filing Date
IS6567A IS6567A (is) 2000-04-28 2002-09-24 Natríum-vetnis skiptilati af gerð 1 (NHE-1)
IS6588A IS6588A (is) 2000-04-28 2002-10-21 Natríum-vetnis skiptis hindri af gerð 1 (NHE-1)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IS6567A IS6567A (is) 2000-04-28 2002-09-24 Natríum-vetnis skiptilati af gerð 1 (NHE-1)

Country Status (40)

Country Link
EP (1) EP1276737A1 (is)
JP (1) JP2003531900A (is)
KR (1) KR20020093079A (is)
CN (1) CN1225466C (is)
AP (1) AP2002002651A0 (is)
AR (1) AR028375A1 (is)
AU (1) AU2001235896A1 (is)
BG (1) BG107139A (is)
BR (1) BR0110268A (is)
CA (1) CA2407535A1 (is)
CO (1) CO5221125A1 (is)
CR (1) CR6797A (is)
CZ (1) CZ20023408A3 (is)
DZ (1) DZ3310A1 (is)
EA (1) EA004882B1 (is)
EE (1) EE200200615A (is)
GT (1) GT200100064A (is)
HN (1) HN2001000042A (is)
HR (1) HRP20020851A2 (is)
HU (1) HUP0300651A2 (is)
IL (1) IL152075A0 (is)
IS (2) IS6567A (is)
MA (1) MA26897A1 (is)
MX (1) MXPA02010600A (is)
MY (1) MY133842A (is)
NO (1) NO20025132L (is)
NZ (1) NZ521348A (is)
OA (1) OA12256A (is)
PA (1) PA8513301A1 (is)
PE (1) PE20011270A1 (is)
PL (1) PL357765A1 (is)
SK (1) SK14872002A3 (is)
SV (1) SV2002000418A (is)
TN (1) TNSN01065A1 (is)
TR (1) TR200202439T2 (is)
UA (1) UA73348C2 (is)
UY (1) UY26680A1 (is)
WO (1) WO2001083470A1 (is)
YU (1) YU79602A (is)
ZA (1) ZA200208605B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1355899A1 (en) * 2001-01-31 2003-10-29 Pfizer Products Inc. Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
WO2003051845A1 (en) * 2001-12-19 2003-06-26 Pfizer Products Inc. Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
MXPA04008646A (es) * 2002-05-02 2004-12-06 Pfizer Prod Inc Tratamiento para la diabetes y complicaciones diabeticas con inhibidores del nhe-1.
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
CA2515939A1 (en) * 2003-02-14 2004-09-02 Smithkline Beecham Corporation Novel compounds
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056729B1 (en) * 1998-02-27 2004-12-29 Pfizer Products Inc. N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia

Also Published As

Publication number Publication date
EE200200615A (et) 2004-04-15
EP1276737A1 (en) 2003-01-22
TR200202439T2 (tr) 2003-02-21
GT200100064A (es) 2002-03-22
CZ20023408A3 (cs) 2004-01-14
NO20025132L (no) 2002-12-12
DZ3310A1 (fr) 2001-11-07
KR20020093079A (ko) 2002-12-12
UA73348C2 (en) 2005-07-15
YU79602A (en) 2006-05-25
HN2001000042A (es) 2001-07-09
AU2001235896A1 (en) 2001-11-12
PL357765A1 (en) 2004-07-26
SV2002000418A (es) 2002-07-03
HRP20020851A2 (en) 2005-02-28
AP2002002651A0 (en) 2002-12-31
CA2407535A1 (en) 2001-11-08
BR0110268A (pt) 2003-12-30
CR6797A (es) 2004-05-17
UY26680A1 (es) 2001-12-28
CN1426404A (zh) 2003-06-25
CO5221125A1 (es) 2002-11-28
EA200201023A1 (ru) 2003-02-27
NZ521348A (en) 2004-09-24
CN1225466C (zh) 2005-11-02
HUP0300651A2 (hu) 2003-07-28
IL152075A0 (en) 2003-05-29
MA26897A1 (fr) 2004-12-20
TNSN01065A1 (fr) 2005-11-10
BG107139A (bg) 2003-07-31
OA12256A (en) 2003-11-06
PA8513301A1 (es) 2003-09-05
IS6567A (is) 2002-09-24
ZA200208605B (en) 2003-10-24
NO20025132D0 (no) 2002-10-25
WO2001083470A1 (en) 2001-11-08
PE20011270A1 (es) 2001-12-12
AR028375A1 (es) 2003-05-07
MXPA02010600A (es) 2003-03-10
MY133842A (en) 2007-11-30
EA004882B1 (ru) 2004-08-26
JP2003531900A (ja) 2003-10-28
SK14872002A3 (sk) 2004-03-02

Similar Documents

Publication Publication Date Title
DK1064298T3 (da) Inhibitorer af caspaser
NO20030845L (no) Utvalgte kondenserte pyrrolokarbazoler
ATE398611T1 (de) Para-amin substituierte phenylamid glukokinase activatoren
DZ3318A1 (fr) Inhibiteur de proteinase
DE50103020D1 (de) Positioniereinheit
AR028393A1 (es) Iminoazidas substituidas
DE50110260D1 (de) Kühlkreislauf
DE60130271D1 (de) Werstückträger
DE50007505D1 (de) Positioniervorrichtung
IS6588A (is) Natríum-vetnis skiptis hindri af gerð 1 (NHE-1)
DE60132814D1 (de) Te
DE69903779D1 (de) Inhibitor- Schalter
DE60122192D1 (de) Schaltungsanordnung
DE60112941D1 (de) Schaltungsanordnung
DE60127966D1 (de) Schaltungsanordnung
DE60117837D1 (de) Schaltungsanordnung
DE50108778D1 (de) Dialkinverbindungen
DE60113842D1 (de) Schaltung
FI20000264A (fi) Aikakauslehtipaperi
NO20000210D0 (no) Spannholder
FI20000385A0 (fi) ISDN-kuulostus
NO20001572D0 (no) Meiselverktøy
NO20005902D0 (no) Hurtigfeste
DK1051973T3 (da) Midler til forbedring af det optiske papillær-kredslöb
SE0001805D0 (sv) New compounds III